Stay updated on Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page
- Check7 days agoChange DetectedThe study status on the page has been updated to Completed and the 'Last Update Posted' field now shows as (Estimated), reflecting the completion of the trial and associated timing information.SummaryDifference0.3%

- Check14 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, with no substantive changes to the study details, eligibility criteria, locations, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed, and the page revision label was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedThe study location entry was corrected from 'Tainan City, Taiwan, 70457' to 'Tainan, Taiwan, 70457' and a funding-status notice block was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedNo additions or deletions were detected on the page; the content appears unchanged.SummaryDifference0.3%

- Check71 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference3%

Stay in the know with updates to Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Monotherapy in Head & Neck Clinical Trial page.